Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy

Church, AlannaCalicchio, MonicaNardi, ValentinaSkálová, AlenaPinto, AndreDillon, DeborahGomez-Fernandez, CarmenManoj, NamithaHaimes, JoshStahl, JoshuaDela Cruz, FilemonTannenbaum-Dvir, SarahGlade-Bender, JuliaKung, AndrewDuBois, StevenKozakewich, HarryJaneway, KatherinePerez-Atayde, AntonioHarris, Marian2022-08-312017-11-03Church, Alanna, Monica Calicchio, Valentina Nardi, Alena Skálová, Andre Pinto, Deborah Dillon, Carmen Gomez-Fernandez et al. "Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy." Mod Pathol 31, no. 3 (2017): 463-473. DOI: 10.1038/modpathol.2017.1270893-39521530-0285https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37373127en-USPathology and Forensic MedicineRecurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategyJournal Article2017-08-3020172022-08-3110.1038/modpathol.2017.127